ea0096p2 | Section | UKINETS2023
Clement Dr. Dominique
, Monique van Leerdam Prof
, Tesselaar Dr. Margot
, Cananea Ms. Elmie
, Martin Ms. Wendy
, Martin Weickert Prof
, Sarker Dr. Debashis
, John Ramage Prof
, Srirajaskanthan Dr. Rajaventhan
Introduction: Patients with neuroendocrine tumours located in the gastroenteropancreatic tract (GEP-NETs) and treatment with somatostatin analogues (SSAs) are at risk of malnutrition which has been reported previously, based on weight loss or body mass index (BMI) only. Since 2019 The Global leadership into malnutrition (GLIM) criteria exist to diagnose malnutrition, including weight loss, BMI and sarcopenia. These GLIM criteria have not been assessed in...